April 14, 2016
Targovax reports immune response with reduced number of TG01 vaccinations
Media
April 14, 2016
WILSON THERAPEUTICS PRESENTS DATA ON DECUPRATE™ (WTX101) FROM ONGOING PHASE 2 STUDY AT THE INTERNATIONAL LIVER CONGRESS™ 2016
April 11, 2016
NORDIC NANOVECTOR ENTERS COLLABORATION WITH PAUL SCHERRER INSTITUTE TO DEVELOP NEW ANTIBODY RADIONUCLIDE CONJUGATES FOR TREATING LEUKAEMIAS
April 06, 2016
Strongbridge Biopharma plc Announces Presentation at 15th Annual Needham Healthcare Conference
April 05, 2016
Altimmune Expands Clinical Development Team
April 04, 2016
Strongbridge Biopharma plc Announces Presentation of COR-003 Data at the Endocrine Society’s 2016 Annual Conference
April 01, 2016
Nexstim Plc Appoints John Liedtky as VP of Commercialisation, General Manager US and announces the retirement of John Hardin
March 31, 2016
Nexstim Plc provides key update on Phase III NICHE stroke therapy trial
March 24, 2016
Strongbridge Biopharma plc Reports Full-Year 2015 Financial Results
March 21, 2016
Onxeo Announces Establishment of U.S. Subsidiary